Published in Gene Therapy Weekly, January 5th, 2006
"Bs-GluDH was cloned, and expressed at considerable magnitude in Escherichia coli," wrote M.I.H. Khan and colleagues, Shimane University.
"The recombinant Bs-GluDH was purified to homogeneity and has been determined to have a hexameric structure (Mr 270 kDa) with strict specificity for 2-oxoglutarate and L-glutamate, requiring NADH and NAD+ as cofactors respectively."
The researchers wrote, "The enzyme showed low thermostability...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.